Larson-Green Julie 4

What Happened

• Julie Larson-Green, a director of Health Catalyst, was granted 80,691 restricted stock units (RSUs) on 2026-07-16. The award is reported as an acquisition (code A) at $0.00 per unit (total reported cash cost $0).
• The filing shows an award/grant rather than a market purchase or sale; director RSU grants are common director compensation and do not reflect an immediate cash investment or sale.

Key Details

• Transaction date: 2026-07-16; Form 4 filed: 2026-07-20 (filed on time under the 2-business-day rule).
• Shares/units granted: 80,691 RSUs; reported acquisition price: $0.00 (no cash paid).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote: Each RSU is a contingent right to one share. Per the plan, RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders.
• Transaction code: A = Award/Grant.

Context

• RSUs are a form of equity compensation that convert into shares when vested; they are not an immediate purchase or sale. For directors, RSU grants are routine compensation and should be interpreted as such rather than a direct bullish or bearish trade signal.